Ligand recognition and activation of formyl peptide receptors in neutrophils - PubMed (original) (raw)
Review
doi: 10.1189/jlb.0905498. Epub 2005 Dec 19.
Affiliations
- PMID: 16365159
- DOI: 10.1189/jlb.0905498
Review
Ligand recognition and activation of formyl peptide receptors in neutrophils
Huamei Fu et al. J Leukoc Biol. 2006 Feb.
No abstract available
Similar articles
- Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
Waller A, Sutton KL, Kinzer-Ursem TL, Absood A, Traynor JR, Linderman JJ, Omann GM. Waller A, et al. Biochemistry. 2004 Jun 29;43(25):8204-16. doi: 10.1021/bi035335i. Biochemistry. 2004. PMID: 15209517 - Multiple receptor states are required to describe both kinetic binding and activation of neutrophils via N-formyl peptide receptor ligands.
Kinzer-Ursem TL, Sutton KL, Waller A, Omann GM, Linderman JJ. Kinzer-Ursem TL, et al. Cell Signal. 2006 Oct;18(10):1732-47. doi: 10.1016/j.cellsig.2006.01.014. Cell Signal. 2006. PMID: 16530386 - The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C. Stenfeldt AL, et al. Biochem Pharmacol. 2007 Oct 1;74(7):1050-6. doi: 10.1016/j.bcp.2007.06.049. Epub 2007 Jul 7. Biochem Pharmacol. 2007. PMID: 17692291 - Formyl Peptide Receptors in Mice and Men: Similarities and Differences in Recognition of Conventional Ligands and Modulating Lipopeptides.
Winther M, Dahlgren C, Forsman H. Winther M, et al. Basic Clin Pharmacol Toxicol. 2018 Feb;122(2):191-198. doi: 10.1111/bcpt.12903. Epub 2017 Nov 28. Basic Clin Pharmacol Toxicol. 2018. PMID: 28881079 Review. - The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. Chiang N, et al. Pharmacol Rev. 2006 Sep;58(3):463-87. doi: 10.1124/pr.58.3.4. Pharmacol Rev. 2006. PMID: 16968948 Review.
Cited by
- Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages.
Gemperle C, Schmid M, Herova M, Marti-Jaun J, Wuest SJ, Loretz C, Hersberger M. Gemperle C, et al. PLoS One. 2012;7(11):e50195. doi: 10.1371/journal.pone.0050195. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185575 Free PMC article. - Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors.
Christenson K, Björkman L, Ahlin S, Olsson M, Sjöholm K, Karlsson A, Bylund J. Christenson K, et al. Front Immunol. 2013 Apr 22;4:92. doi: 10.3389/fimmu.2013.00092. eCollection 2013. Front Immunol. 2013. PMID: 23626589 Free PMC article. - Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.
Zhang P, Covic L, Kuliopulos A. Zhang P, et al. Methods Mol Biol. 2015;1324:191-203. doi: 10.1007/978-1-4939-2806-4_13. Methods Mol Biol. 2015. PMID: 26202271 Free PMC article. - The annexin I sequence gln(9)-ala(10)-trp(11)-phe(12) is a core structure for interaction with the formyl peptide receptor 1.
Movitz C, Brive L, Hellstrand K, Rabiet MJ, Dahlgren C. Movitz C, et al. J Biol Chem. 2010 May 7;285(19):14338-45. doi: 10.1074/jbc.M109.080465. Epub 2010 Mar 10. J Biol Chem. 2010. PMID: 20220135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources